Obstetrical & Gynecological Survey

Papers
(The H4-Index of Obstetrical & Gynecological Survey is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Variables Associated With Resolution and Persistence of Ovarian Cysts77
Improved Survival in Cervical Cancer Patients Receiving Care at National Cancer Institute–Designated Cancer Centers49
Position and Integrity of Uterine Scar Are Determined by Degree of Cervical Dilatation at Time of Cesarean Section41
Pilot Randomized Controlled Trial of Diabetes Group Prenatal Care39
Accuracy of Surgeon Self-Reflection on Hysterectomy Quality Metrics33
Timing of Diagnosis of Fetal Structural Abnormalities After the Introduction of Universal Cell-Free DNA in the Absence of First-Trimester Anatomical Screening32
The Association of Preoperative Medication Administration and Preoperative and Intraoperative Factors With Postoperative Urinary Retention After Urogynecologic Surgery25
CME PROGRAM EXAM AND ANSWER SHEET25
Association of Simulation Training With Rates of Medical Malpractice Claims Among Obstetrician-Gynecologists20
Does Aspirin Prescribed to Women Deemed High Risk for Preterm Pre-Eclampsia at 11–13+6 Weeks Gestation Affect the Prevalence of Small for Gestational Age Neonates?20
Who Places High Value on the Uterus? A Cross-sectional Survey Study Evaluating Predictors for Uterine Preservation19
Defining Properly Collected Urine: Thresholds to Improve the Accuracy of Urinalysis for Microscopic Hematuria Evaluation in Women19
The Reckoning: The Return of Genomic Results to 1444 Participants Across the eMERGE3 Network18
Cesarean Delivery Trends Among Patients at Low Risk for Cesarean Delivery in the US, 2000–201918
Epidemiologic and Genetic Associations of Endometriosis With Depression, Anxiety, and Eating Disorders17
Long-term Health-Related Quality of Life and Symptom Severity Following Hysterectomy, Myomectomy, or Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids17
0.063226938247681